Mechanism of Action - The Central Command Override
- Central Action: Primarily act on α2-adrenergic receptors in the brainstem (nucleus tractus solitarii).
- Sympathetic Reduction: This stimulation mimics a negative feedback loop, leading to ↓ sympathetic outflow from the CNS.
- Peripheral Effects:
- Results in decreased norepinephrine (NE) release at peripheral nerve endings.
- Leads to ↓ peripheral vascular resistance and ↓ cardiac output, thus lowering blood pressure.
⭐ Abrupt discontinuation, especially of clonidine, can cause severe rebound hypertension and tachycardia due to a surge in sympathetic activity.
Indications & Contraindications - Green Lights & Red Flags
Indications (Green Lights ✅)
- Hypertension: Primarily for resistant HTN. Methyldopa is a choice for pregnancy-induced hypertension.
- ADHD: Guanfacine and Clonidine serve as non-stimulant treatment options.
- Symptom Management (Clonidine):
- Opioid & nicotine withdrawal symptoms.
- Menopausal hot flashes.
- Tourette syndrome tics.
Contraindications (Red Flags 🚫)
- Abrupt Discontinuation: ⚠️ High risk of severe rebound hypertension and tachycardia. Must taper dose slowly.
- Elderly Patients: Increased risk of CNS effects and orthostatic hypotension (Beers List).
- Depression: Can cause or exacerbate depressive symptoms.
⭐ Methyldopa is a key choice for hypertension in pregnancy but is famously associated with drug-induced lupus and hemolytic anemia (positive Coombs test).
Adverse Effects - The Rebound & Sedation Show
-
Central Nervous System (CNS): The most frequent, dose-dependent effects.
- Sedation, fatigue, and dizziness.
- Depression can occur, limiting use in susceptible patients.
-
Cardiovascular System:
- ⚠️ Rebound Hypertension: Abrupt withdrawal is critical to avoid. It leads to a surge in sympathetic outflow, causing severe ↑BP, tachycardia, and nervousness. Always taper the dose slowly over several days.
- Bradycardia and orthostatic hypotension.
-
Other Common Effects:
- Dry mouth (xerostomia) and constipation.
- Sodium and water retention, often resulting in edema.
⭐ Methyldopa-Specific: Can cause a positive Coombs test in up to 20% of patients, which may lead to hemolytic anemia. It can also induce hepatitis or a lupus-like syndrome.
Key Agents - Clonidine, Guanfacine, Methyldopa
| Feature | Clonidine | Guanfacine | Methyldopa |
|---|---|---|---|
| Primary Use | HTN, ADHD, Tourette's | HTN, ADHD | HTN in Pregnancy |
| α2 Selectivity | Less selective | More selective (vs α1) | Acts as false neurotransmitter |
| Key Side Effect | Rebound HTN upon abrupt cessation | Less sedation & rebound HTN | Drug-induced lupus, +Coombs test |
| Clinical Pearl | Useful for opioid/nicotine withdrawal sx | Longer half-life than clonidine | Safe in pregnancy |
⭐ Methyldopa can cause a positive Coombs test, sometimes leading to hemolytic anemia. It's a classic exam question linking a drug to a specific autoimmune-like reaction.

High‑Yield Points - ⚡ Biggest Takeaways
- Mechanism: Centrally acting α2-agonists that ↓ sympathetic outflow from the brainstem, leading to reduced blood pressure.
- Clonidine is used for hypertensive urgency and ADHD; abrupt discontinuation causes severe rebound hypertension.
- α-Methyldopa is a first-line agent for hypertension in pregnancy.
- Key side effects of methyldopa include drug-induced lupus and Coombs-positive hemolytic anemia.
- Common adverse effects for the class include sedation, dry mouth, and bradycardia.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app